Related Experiment Video
Updated: Sep 19, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
[Drug-induced Parkinsonism: A Psychiatric Perspective]
Shinto Kitada1, Takashi Tsuboi
1Department of Neuropsychiatry, Kyorin University School of Medicine.
None:
Drug-induced parkinsonism (DIP) refers to a parkinsonian syndrome resulting from the use of drugs, such as antipsychotics, whose primary mechanism of action is dopamine receptor blockade. The clinical features of DIP typically include action tremors, muscular stiffness, slowness of movement, and postural instability, often with minimal lateral asymmetry. The diagnosis of DIP requires a thorough review of the patient's medication history and the exclusion of differential disorders, and the recommended management is discontinuation or dose reduction of the potentially causative agent. In patients with schizophrenia, switching the offending antipsychotic to another, preferably second-generation antipsychotic agent, is also recommended. This treatment strategy can be adapted to prevent DIP as well.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...